MOLECULAR SIGNATURE IN SUSTAINED CLINICAL REMISSION INDUCED BY TOCILIZUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS

被引：0
|
作者：
Kajio, N. [1 ]
Suzuki, K. [1 ]
Matsumoto, K. [1 ]
Iijima, H. [2 ]
Nakamura, S. [2 ]
Ishizawa, Y. [2 ]
Inamo, J. [1 ]
Takeshita, M. [1 ]
Yoshimoto, K. [1 ]
Kaneko, Y. [1 ]
Takeuchi, T. [1 ]
机构：
[1] Keio Univ, Sch Med, Div Rheumatol, Dept Internal Med, Tokyo, Japan
[2] DNA Chip Res Inc, Div Res, Tokyo, Japan
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2022年 / 81卷
关键词：
D O I：
10.1136/annrheumdis-2022-eular.1680
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS0530
引用
收藏
页码：526 / 526
页数：1
相关论文
共 50 条
  • [1] Sustained Clinical Remission and Rate of Relapse After Tocilizumab Withdrawal in Patients with Rheumatoid Arthritis
    Aguilar-Lozano, Luis
    Dionisio Castillo-Ortiz, Jose
    Vargas-Serafin, Cesar
    Morales-Torres, Jorge
    Sanchez-Ortiz, Adriana
    Sandoval-Castro, Carlos
    Padilla-Ibarra, Jorge
    Hernandez-Cuevas, Claudia
    Ramos-Remus, Cesar
    [J]. JOURNAL OF RHEUMATOLOGY, 2013, 40 (07) : 1069 - 1073
  • [2] SUBCLINICAL SYNOVITIS IN PATIENTS WITH RHEUMATOID ARTHRITIS ON SUSTAINED CLINICAL REMISSION
    Rojas, Elias
    Valinotti, Vannia
    Vazquez, Marcos
    Roman, Lourdes
    Cabrera-Villalba, Sonia
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2020, 26 : 71 - 72
  • [3] IDENTIFICATION OF SYNOVITIS IN PATIENTS WITH RHEUMATOID ARTHRITIS IN CLINICAL REMISSION DURING THERAPY WITH TOCILIZUMAB
    Panasyuk, E.
    Smirnov, A.
    Fedorenko, E.
    Gavva, T.
    Gubar, E.
    Loginova, E.
    Lukina, G.
    Luchikhina, E.
    Tsvetkova, E.
    Avdeeva, A.
    Alexandrova, E.
    Nasonov, E.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 508 - 509
  • [4] Reduced dose of tocilizumab for the maintenance of remission in patients with rheumatoid arthritis: a clinical experience
    Epis, Oscar
    Casu, Cinzia
    Belloli, Laura
    Schito, Emanuela
    Filippini, Davide
    Muscara, Marina
    Bruschi, Eleonora
    [J]. RHEUMATOLOGY INTERNATIONAL, 2015, 35 (09) : 1569 - 1570
  • [5] Reduced dose of tocilizumab for the maintenance of remission in patients with rheumatoid arthritis: a clinical experience
    Oscar Epis
    Cinzia Casu
    Laura Belloli
    Emanuela Schito
    Davide Filippini
    Marina Muscarà
    Eleonora Bruschi
    [J]. Rheumatology International, 2015, 35 : 1569 - 1570
  • [6] Demographics and clinical characteristics associated with sustained remission and continuation of sustained remission in patients with rheumatoid arthritis treated with adalimumab
    Noriko Kimura
    Katsuya Suzuki
    Tsutomu Takeuchi
    [J]. Inflammation and Regeneration, 39
  • [7] Demographics and clinical characteristics associated with sustained remission and continuation of sustained remission in patients with rheumatoid arthritis treated with adalimumab
    Kimura, Noriko
    Suzuki, Katsuya
    Takeuchi, Tsutomu
    [J]. INFLAMMATION AND REGENERATION, 2019, 39 (1)
  • [8] Sustained rheumatoid arthritis remission is uncommon in clinical practice
    Femke HM Prince
    Vivian P Bykerk
    Nancy A Shadick
    Bing Lu
    Jing Cui
    Michelle Frits
    Christine K Iannaccone
    Michael E Weinblatt
    Daniel H Solomon
    [J]. Arthritis Research & Therapy, 14
  • [9] Clinical Remission and Rate of Relapse After Tocilizumab Withdrawal in Rheumatoid Arthritis Patients.
    Vargas-Serafin, Cesar
    Aguilar-Lozano, Luis
    Padilla-Ibarra, Jorge
    Sandoval-Castro, Carlos
    Dionisio Castillo-Ortiz, Jose
    Morales-Torres, Jorge
    Hernandez, Claudia
    Ramos-Remus, Cesar
    [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S193 - S193
  • [10] PREDICTIVE FACTORS OF SUSTAINED CLINICAL REMISSION IN RHEUMATOID ARTHRITIS
    Fakhfakh, R.
    El Amri, N.
    Baccouche, K.
    Zeglaoui, H.
    Bouajina, E.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1099 - 1099
12345